MTOR and neoplasm: M2 macrophages, instead, are activated by anti-inflammatory cytokines (interleukine-4 and interleukine-10) and the PI3K/AKT/mTOR pathway, and exert immunosuppressive effects associated with enhanced angiogenesis and tumor progression, pushing OTS cells in stemness status [78,82,83].